Efficacy and safety of rivaroxaban in patients with inferior vena cava filter placement without anticoagulation contraindications (EPICT): a prospective randomised controlled trial study protocol.
Libin ZhangMiaomiao LiYuefeng ZhuZhenyu ShiWan ZhangBin GaoLubin LiZhengdong FangGuangwei YangWei HanLinjun WangLi YinXueying KeJianing YueZheng GuZhenjie LiuPublished in: BMJ open (2021)
The study was approved by the Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (approval number: (2019) 295). The results will be disseminated through presentations at scientific conferences and publications in peer-reviewed journals TRIAL REGISTRATION NUMBER: NCT04066764.
Keyphrases
- study protocol
- inferior vena cava
- pulmonary embolism
- randomized controlled trial
- venous thromboembolism
- atrial fibrillation
- clinical trial
- endothelial cells
- vena cava
- physical activity
- open label
- drug administration
- healthcare
- public health
- mental health
- big data
- phase iii
- phase ii
- acute care
- induced pluripotent stem cells
- double blind
- pluripotent stem cells
- deep learning
- placebo controlled
- meta analyses
- high school
- electronic health record